General
In a sensational case study published in Nature Communicationsresearchers report an innovative therapeutic approach in a young child with a difficult-to-treat infection caused by an extensively drug-resistant (XDR) Pseudomonas aeruginosa bacterium following a liver transplant. This study illustrates the great potential of combining bacteriophage therapy with antibiotics in the fight against dangerous, multi-resistant germs.
Post-operative bacterial infections pose a major risk in liver transplants – especially in young children with weakened immune systems. Due to the increasing resistance to common antibiotics, classic therapies are often ineffective. This was precisely the case with the young patient: after the first liver transplant, the child developed sepsis caused by an extremely resistant strain of P. aeruginosa. The usual antibiotic therapy failed – a medical emergency that called for new approaches.
Bacteriophages – or phages for short – are viruses that specifically attack and destroy bacteria. Phage therapy is not new, but is making a strong comeback in the face of increasing antibiotic resistance. In the present study, a personalized combination of intravenously administered phages and antibiotics was used over a period of 86 days. The aim was to combine the effect of both agents and thus effectively combat the resistant infection.
The combined therapy was very well tolerated by the child – there were no side effects and there was no neutralization of the phages by the immune system. The decisive factor, however, was the medical success: the infection receded, the general condition improved and a second, successful liver transplant could be performed. Laboratory tests confirmed the effectiveness: the phages and antibiotics together were more effective against the bacteria than each alone. Although some bacteria showed resistance to individual phages in the course of the treatment, this did not affect the overall success – possibly because the phages simultaneously reduced the virulence, i.e. the dangerousness of the bacteria.
This case study impressively demonstrates that the combination therapy of phages and antibiotics can be a life-saving option for difficult-to-treat infections – especially in patients with impaired immune defenses or after transplants. The fact that this method could even be used so successfully and without side effects in an infant opens the door to further clinical studies and wider application in modern medicine.
When traditional antibiotics fail, new solutions are needed – and this study provides one such solution. The targeted combination of bacteriophages and antibiotics shows how even extremely resistant germs can be tackled effectively. For many patients with previously hopeless infections, this means real hope – and for medicine, a powerful new tool in the fight against resistant pathogens.
The balance of your skin is our motivation
We are convinced that we can also do something good for your skin.
99.3% of our customers agree.
Our aim is to satisfy you with our products. If we still can’t convince you, you’ll get your money back*.
